Amedisys Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Revenue	2,236	2,223	2,214	2,072	1,956	Upgrade
Revenue Growth (YoY)	0.59%	0.41%	6.88%	5.93%	17.63%	Upgrade
Cost of Revenue	1,246	1,260	1,233	1,185	1,150	Upgrade
Gross Profit	990.87	962.77	980.76	886.15	805.3	Upgrade
Selling, General & Admin	516.05	508.79	474.72	449.45	394.45	Upgrade
Other Operating Expenses	318.43	270.2	254.12	217.43	233.37	Upgrade
Operating Expenses	834.48	778.99	728.84	666.88	627.82	Upgrade
Operating Income	156.39	183.78	251.92	219.27	177.47	Upgrade
Interest Expense / Income	31.27	22.23	9.53	11.04	14.52	Upgrade
Other Expense / Income	84.31	0.4	-36.75	-1.01	-6.38	Upgrade
Pretax Income	40.81	161.15	279.14	209.24	169.34	Upgrade
Income Tax	50.56	42.55	70.07	25.64	42.5	Upgrade
Net Income	-9.75	118.61	209.07	183.61	126.83	Upgrade
Net Income Growth	-	-43.27%	13.87%	44.76%	6.27%	Upgrade
Shares Outstanding (Basic)	33	33	33	33	32	Upgrade
Shares Outstanding (Diluted)	33	33	33	33	33	Upgrade
Shares Change	-0.17%	-0.97%	-0.89%	0.84%	-1.84%	Upgrade
EPS (Basic)	-0.30	3.65	6.41	5.64	3.95	Upgrade
EPS (Diluted)	-0.30	3.63	6.34	5.52	3.84	Upgrade
EPS Growth	-	-42.74%	14.86%	43.75%	8.17%	Upgrade
Free Cash Flow	131.7	127.18	182.74	283.7	194.27	Upgrade
Free Cash Flow Per Share	4.04	3.91	5.60	8.71	6.04	Upgrade
Gross Margin	44.31%	43.31%	44.30%	42.78%	41.18%	Upgrade
Operating Margin	6.99%	8.27%	11.38%	10.58%	9.07%	Upgrade
Profit Margin	-0.44%	5.34%	9.44%	8.86%	6.49%	Upgrade
Free Cash Flow Margin	5.89%	5.72%	8.25%	13.70%	9.93%	Upgrade
Effective Tax Rate	123.88%	26.40%	25.10%	12.25%	25.10%	Upgrade
EBITDA	129.93	254.35	359.93	288.22	238.18	Upgrade
EBITDA Margin	5.81%	11.44%	16.26%	13.91%	12.18%	Upgrade
Depreciation & Amortization	57.84	70.96	71.27	67.94	54.33	Upgrade
EBIT	72.09	183.38	288.66	220.28	183.85	Upgrade
EBIT Margin	3.22%	8.25%	13.04%	10.63%	9.40%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).